Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 172  Show
  1. 1
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 16 other entries.

  2. 2
    "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor."
    Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Mueller M.A., Drosten C., Poehlmann S.
    Cell 181:1-10(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION (SPIKE PROTEIN S1), CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
    Category: Function, PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3 and mapped to 2 other entries.

  3. 3
    "A multibasic cleavage site in the Spike protein of SARS-CoV-2 is essential for infection of human lung cells."
    Hoffmann M., Kleine-Weber H., Poehlmann S.
    Mol. Cell 78:779-784(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, FUNCTION, MUTAGENESIS OF 681-PRO--ALA-684.
    Category: Function, Pathology & Biotech, PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 1 other entries.

  4. 4
    "Site-specific glycan analysis of the SARS-CoV-2 spike."
    Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M.
    Science 369:330-333(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY.
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed). ORCID:0000-0002-4650-631X (see community submission).

    This publication is mapped to 28 other entries.

  5. 5
    "Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2."
    Shajahan A., Supekar N.T., Gleinich A.S., Azadi P.
    Glycobiology 30:981-988(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION AT ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234; ASN-282; THR-323; SER-325; ASN-331; ASN-343; ASN-616; ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY.
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 6 other entries.

  6. 6
    "Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide."
    Isabel S., Grana-Miraglia L., Gutierrez J.M., Bundalovic-Torma C., Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T., Guttman D.S., Poutanen S.M.
    Sci. Rep. 10:14031-14031(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT GLY-614.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  7. 7
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  8. 8
    Category: Function.
    Source: UniProtKB/Swiss-Prot (reviewed).
  9. 9
    "Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition."
    Grant O.C., Montgomery D., Ito K., Woods R.J.
    Sci. Rep. 10:14991-14991(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: GLYCOSYLATION.
    Category: PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).
  10. 10
    Cited for: GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, SUBUNIT.
    Category: Subcellular Location, PTM / Processing, Interaction, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  11. 11
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  12. 12
    Category: Function, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 and mapped to 8 other entries.

  13. 13
    Category: Function, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 15 and mapped to 12 other entries.

  14. 14
    "The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection."
    Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y., Kolls J.K., Bix G.J.
    JACC Basic Transl. Sci. 6:1-8(2021) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HUMAN ITGA5 AND ITGB1.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3 other entries.

  15. 15
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  16. 16
    "D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction."
    Gobeil S.M., Janowska K., McDowell S., Mansouri K., Parks R., Manne K., Stalls V., Kopp M.F., Henderson R., Edwards R.J., Haynes B.F., Acharya P.
    Cell Rep. 34:108630-108630(2021) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT GLY-614.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  17. 17
    "Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020."
    Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.
    Eurosurveillance 26:0-0(2021) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS 69-VAL--PHE-70 DEL; LYS-144 DEL; TYR-501; ASP-570; GLY-614; HIS-681; ILE-716; ALA-982 AND HIS-1118.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 5 other entries.

  18. 18
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  19. 19
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 5 other entries.

  20. 20
    "The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity."
    Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H., Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X., Huang W., Wang Y.
    Cell 182:1284-1294(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: MUTAGENESIS OF ASN-165; ASN-234; ASN-331; ASN-343; LEU-452; ALA-475; VAL-483; PHE-490 AND HIS-519.
    Category: Pathology & Biotech.
    Source: UniProtKB/Swiss-Prot (reviewed).
  21. 21
    "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV."
    Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z.
    Nat. Commun. 11:1620-1620(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST CTSL, INTERACTION WITH HUMAN ACE2.
    Category: Function, PTM / Processing, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 4 other entries.

  22. 22
    "Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction."
    Cao W., Dong C., Kim S., Hou D., Tai W., Du L., Im W., Zhang X.F.
    Biophys. J. 120:1011-1019(2021) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH HUMAN ACE2.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 1 other entry.

  23. 23
    "Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2."
    Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M.
    PLoS Pathog. 17:e1009212-e1009212(2021) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
    Category: Function, PTM / Processing.
    Source: UniProtKB/Swiss-Prot (reviewed).
  24. 24
    "The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles."
    Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L., Lavillette D., Denolly S.
    J. Biol. Chem. 296:100111-100111(2020) [PubMed] [Europe PMC] [Abstract]
    Cited for: SUBCELLULAR LOCATION, INTERACTION WITH S PROTEIN.
    Category: Subcellular Location, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  25. 25
    Category: Sequences.
    Strain: 20H/501Y.V2, B.1.351 and Beta.
    Source: UniProtKB/Swiss-Prot (reviewed).
1 to 25 of 172  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again